The General Clinical Research Center of Emory University has a long history of outstanding clinical research. The primary objective of this 5-Year renewal application is to provide the facilities and resources whereby both the existing and an increasing number of outstanding new basic science and clinical investigators can pursue important areas of clinical research.
The specific aims and major areas of research proposed are outlined in 44 defined protocols involving 76 investigators. These include: 1) studies on chronic liver diseases and complications such as metabolic bone disease; studies of hepatic function and hemodynamics in liver disease, including the effects of liver transplantation and modulation of hemodynamics by a variety of pharmacologic agents; 2) studies of kidney disease, including the mechanisms by which nutritional intervention might retard progression to end-stage renal disease; 3) studies in endocrinology, including obesity; alterations in glucose and lactate metabolism; insulin resistance and diabetes; genetic regulation of insulin receptors; therapeutic trials with growth hormone; and nutritional regulation of somatomedin and somatomedin inhibitors; 4) studies in hematology/oncology, including investigation of platelet production and destruction; 5) studies in cardiology, comparing balloon angioplasty with bypass graft surgery for treatment of coronary artery disease; 6) studies of inherited disorders of mitochondrial function, including the mitochondrial myopathies, and molecular approaches to nuclear mutations such as the Emery-Dreifuss muscular dystrophy; and 7) studies of inborn errors of metabolism, especially the enzymatic and molecular mechanisms producing maple syrup urine disease, phenylketonuria, hemochromatosis and porphyria. Overall, these projects focus on important medical, surgical and pediatric health disorders for which new discoveries and treatments could have a major impact. To accomplish these aims, we offer an outstanding team of existing and new investigators, a wealth of patient material from the Emory University Affiliated Hospitals and Clinic, a tightly administered 12-bed clinical research facility with experienced research nurses, a core laboratory with expertise in metabolic balance studies, a nutrition/calorimetry team and metabolic kitchen, a newly developed and equipped molecular biology laboratory, a highly organized biostatistical support unit and CLINFO computer resource, and a University with a vital commitment to excellence in research.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
General Clinical Research Centers Program (M01)
Project #
5M01RR000039-33
Application #
3089255
Study Section
General Clinical Research Centers Committee (CLR)
Project Start
1974-10-01
Project End
1994-11-30
Budget Start
1992-12-01
Budget End
1993-11-30
Support Year
33
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Emory University
Department
Type
Schools of Medicine
DUNS #
042250712
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Askie, Lisa M; Darlow, Brian A; Finer, Neil et al. (2018) Association Between Oxygen Saturation Targeting and Death or Disability in Extremely Preterm Infants in the Neonatal Oxygenation Prospective Meta-analysis Collaboration. JAMA 319:2190-2201
Logue, Mark W; van Rooij, Sanne J H; Dennis, Emily L et al. (2018) Smaller Hippocampal Volume in Posttraumatic Stress Disorder: A Multisite ENIGMA-PGC Study: Subcortical Volumetry Results From Posttraumatic Stress Disorder Consortia. Biol Psychiatry 83:244-253
McKenzie, Katelyn A; El Ters, Mirelle; Torres, Vicente E et al. (2018) Relationship between caffeine intake and autosomal dominant polycystic kidney disease progression: a retrospective analysis using the CRISP cohort. BMC Nephrol 19:378
Dad, Taimur; Abebe, Kaleab Z; Bae, K Ty et al. (2018) Longitudinal Assessment of Left Ventricular Mass in Autosomal Dominant Polycystic Kidney Disease. Kidney Int Rep 3:619-624
O'Connell, Chloe P; Goldstein-Piekarski, Andrea N; Nemeroff, Charles B et al. (2018) Antidepressant Outcomes Predicted by Genetic Variation in Corticotropin-Releasing Hormone Binding Protein. Am J Psychiatry 175:251-261
Yu, Alan S L; Shen, Chengli; Landsittel, Douglas P et al. (2018) Baseline total kidney volume and the rate of kidney growth are associated with chronic kidney disease progression in Autosomal Dominant Polycystic Kidney Disease. Kidney Int 93:691-699
Stevens, Jennifer S; Reddy, Renuka; Kim, Ye Ji et al. (2018) Episodic memory after trauma exposure: Medial temporal lobe function is positively related to re-experiencing and inversely related to negative affect symptoms. Neuroimage Clin 17:650-658
Huang, Yunfeng; Hui, Qin; Walker, Douglas I et al. (2018) Untargeted metabolomics reveals multiple metabolites influencing smoking-related DNA methylation. Epigenomics 10:379-393
Nowak, Kristen L; You, Zhiying; Gitomer, Berenice et al. (2018) Overweight and Obesity Are Predictors of Progression in Early Autosomal Dominant Polycystic Kidney Disease. J Am Soc Nephrol 29:571-578
Lin, Cliff; Michopoulos, Vasiliki; Powers, Abigail et al. (2018) Affect, inflammation, and health in urban at-risk civilians. J Psychiatr Res 104:24-31

Showing the most recent 10 out of 675 publications